Cannabis Science Senior Executives Arrive at the Global Health Catalyst Summit at Harvard Medical School

IRVINE, CA--(Marketwired - Apr 29, 2017) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, has kicked off its participation in the Global Health Catalyst (GHC) Summit at Harvard Medical School.

CBIS' President, CEO, and Co-Founder, Mr. Raymond C. Dabney, leads a delegation of senior CBIS executives and representatives, including Dr. Allen Herman, CBIS' Chief Medical Officer; Honorable Ronald V. Dellums, Chairman of CBIS' International Government Affairs Board, and former Chairman of the U.S. House of Representatives' Armed Services Committee; Dr. Julius Garvey, a Member of CBIS' Scientific Advisory and International Government Affairs Boards, and Founder/Medical Director of Garvey Vascular Specialists; Ms. Julia Royall, a Member of CBIS' Scientific Advisory Board, and an international health information expert; and Mr. Melvin Foote, a Member of CBIS' International Government Affairs Board, and Founder, President, and CEO of the Constituency for Africa.

The GHC Summit is a premier yearly event designed to catalyze high-impact international collaborations to eliminate global health disparities, with the main focus on cancer and related diseases. The GHC is seed-funded by the Department of Radiation Oncology, Dana Farber Cancer Institute, Brigham and Women's Hospital, and the Radcliffe Institute for Advanced Studies at Harvard University. Information on the GHC Summit can be accessed at https://www.globalhealthcatalystsummit.org/.

Delegates to the GHC Summit will participate in twelve (12) sessions over three days. On Sunday, April 30th, Dr. Herman, CBIS' CMO, will deliver a presentation on the Global Pain Divide at the Palliative Care and Mental Health Session, scheduled to start at 10:00 a.m. EST. This session will be streamed live, and can be viewed at:
http://video.dfcionline.org/accordent/GHCSummitB043017.

Mr. Dabney, CBIS' President, CEO, and Co-Founder, will be the keynote speaker and a panelist for the Medical Cannabis Science versus Cancer & Other Malignancies Session on Sunday, April 30th, scheduled to start at 2:00 p.m. EST. Mr. Dabney will discuss how cannabinoids can be used to treat cancer and other diseases, and CBIS' vision for the global health and development impact of cannabinoid-based medicines. This session will be streamed live, and can be viewed at: http://video.dfcionline.org/accordent/GHCSummitC043017.